Recent

% | $
Quotes you view appear here for quick access.

Biogen Inc. Message Board

  • chicagonorth chicagonorth Mar 6, 2013 5:09 AM Flag

    Innovative biotech with over 100 % revenue growth in both 2011 and 2012 - BLFS

    Zacks small-cap research /posted on their yahoo.finance summary/ puts a price target of 0.5 - 0.7 for BLFS from the current of $ 0.25. The company is a leader in the biopreservation media products designed for the growing regenerative medicine field. The expected yearly growth in the regenerative medicine sector is over 20 %, from the current 1.4 B to 10 B in 2020.

    Sentiment: Strong Buy

 
BIIB
308.17+1.32(+0.43%)Aug 26 4:00 PMEDT